The following is from the
PLoS Biology Editorial and Publishing Policies
"PLoS Medicine, PLoS Biology and PLoS ONE do not consider for publication papers where any of the research costs or authors' salaries have been funded, in whole or in part, by a tobacco company. "
Discuss
4 comments:
What about funding from marijuana growers?
I guess that must be fine. Tobacco is the only industry they explicitly exclude.
That's a narrow exclusion. If you're not going to exclude all the big vested interests, why bother excluding tobacco? I hazard to bet tobacco has more undiscovered benefits than can be offered by the dioxin manufacturers of America.
Tobacco has a particularly egregious record of funding fake science. It is certainly true they are not the only culprits, but they certainly do deserve to be picked on in this case.
Plos also has the policy of require authors to state in writing whether their research is funded or influenced by any organization with any financial interest in the result.
Post a Comment